Cannara Biotech Inc.
LOVFF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$198.55M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $198.55 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0.14 |
| Beta | 0.39 |
| Outstanding Shares | 98,782,148 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 17.69 |
|---|---|
| PEG | 104.63 |
| Price to Sales | 1.43 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
July 15, 2026
EPS Estimate
$0.04
Consensus analyst estimateRevenue Estimate
$22.63 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 23, 2026
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$24.92 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cannara Biotech Inc.
452 employees
CEO: Zohar Krivorot
Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing bo...